• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺血管疾病:血流动力学评估与治疗选择——聚焦于第II组肺动脉高压

Pulmonary Vascular Disease: Hemodynamic Assessment and Treatment Selection-Focus on Group II Pulmonary Hypertension.

作者信息

Ramu Bhavadharini, Houston Brian A, Tedford Ryan J

机构信息

Division of Cardiology, Department of Medicine, Medical University of South Carolina (MUSC), Strom Thurmond Gazes Building, Room 215, 114 Doughty St/MSC592, Charleston, SC, 29425, USA.

出版信息

Curr Heart Fail Rep. 2018 Apr;15(2):81-93. doi: 10.1007/s11897-018-0377-9.

DOI:10.1007/s11897-018-0377-9
PMID:29417467
Abstract

PURPOSE OF REVIEW

Pulmonary hypertension due to left heart disease (PH-LHD) is the most common cause of pulmonary hypertension worldwide, yet therapies used to treat pulmonary arterial hypertension have failed to show efficacy in this population. Proper hemodynamic assessment and differentiation of pulmonary hypertension phenotypes is therefore critical for both current clinical practice and future research and therapeutic efforts.

RECENT FINDINGS

Substantial recent efforts have sought to improve the hemodynamic characterization of pulmonary hypertension for both diagnostic and prognostic purposes. These efforts include identifying occult LHD using provocative maneuvers as well as sub-classifying PH-LHD based on the presence or absence of a pre-capillary component. How to best define the pre-capillary component remains controversial as several studies have drawn conflicting conclusions. The lack of standardization of hemodynamic measurements as well as measurement fidelity concerns may explain some of the discrepant results. Non-hemodynamic methods of PH-LHD classification may also have an emerging role. Despite recent advances, therapeutic studies have largely remained disappointing. In this review, we discuss the nuances and controversies surrounding diagnostic and prognostic hemodynamic characterization of PH-LHD as well as summarize the recent therapeutic efforts and ongoing challenges in this population.

摘要

综述目的

左心疾病所致肺动脉高压(PH-LHD)是全球肺动脉高压最常见的病因,但用于治疗肺动脉高压的疗法在该人群中未能显示出疗效。因此,正确的血流动力学评估和肺动脉高压表型的鉴别对于当前临床实践以及未来的研究和治疗工作都至关重要。

最新发现

最近大量研究致力于改善肺动脉高压的血流动力学特征描述,以用于诊断和预后评估。这些努力包括使用激发试验识别隐匿性左心疾病,以及根据是否存在毛细血管前成分对PH-LHD进行亚分类。由于多项研究得出了相互矛盾的结论,如何最佳定义毛细血管前成分仍存在争议。血流动力学测量缺乏标准化以及测量准确性问题可能解释了一些不一致的结果。PH-LHD分类的非血流动力学方法可能也将发挥越来越重要的作用。尽管最近取得了进展,但治疗研究在很大程度上仍然令人失望。在本综述中,我们讨论了围绕PH-LHD诊断和预后血流动力学特征描述的细微差别和争议,并总结了该人群最近的治疗努力和持续面临的挑战。

相似文献

1
Pulmonary Vascular Disease: Hemodynamic Assessment and Treatment Selection-Focus on Group II Pulmonary Hypertension.肺血管疾病:血流动力学评估与治疗选择——聚焦于第II组肺动脉高压
Curr Heart Fail Rep. 2018 Apr;15(2):81-93. doi: 10.1007/s11897-018-0377-9.
2
Pressure reflection in the pulmonary circulation by echocardiography in patients with left heart disease indicates reactive pulmonary hypertension.超声心动图检测左心疾病患者肺循环中的压力反射提示反应性肺动脉高压。
Int J Cardiol. 2013 Oct 9;168(4):4222-7. doi: 10.1016/j.ijcard.2013.07.153. Epub 2013 Aug 6.
3
Pulmonary hypertension due to left heart diseases.左心疾病所致肺动脉高压。
J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D100-8. doi: 10.1016/j.jacc.2013.10.033.
4
Pulmonary Hypertension Due to Left Heart Disease: Diagnosis, Pathophysiology, and Therapy.左心疾病所致肺动脉高压:诊断、病理生理学与治疗。
Hypertension. 2020 Jun;75(6):1397-1408. doi: 10.1161/HYPERTENSIONAHA.119.14330. Epub 2020 Apr 27.
5
Clinical phenotypes and outcomes of pulmonary hypertension due to left heart disease: Role of the pre-capillary component.左心疾病所致肺动脉高压的临床表型和结局:毛细血管前成分的作用。
PLoS One. 2018 Jun 19;13(6):e0199164. doi: 10.1371/journal.pone.0199164. eCollection 2018.
6
Pulmonary hypertension associated with left-sided heart disease.与左心疾病相关的肺动脉高压。
Swiss Med Wkly. 2017 Jan 17;147:w14395. doi: 10.57187/smw.2017.14395. eCollection 2017.
7
Prognostic value and diagnostic properties of the diastolic pulmonary pressure gradient in patients with pulmonary hypertension and left heart disease.肺动脉高压合并左心疾病患者舒张期肺动静脉压力梯度的预后价值及诊断特性。
Int J Cardiol. 2019 Sep 1;290:138-143. doi: 10.1016/j.ijcard.2019.05.016. Epub 2019 May 13.
8
Left ventricular heart failure and pulmonary hypertension.左心室心力衰竭和肺动脉高压。
Eur Heart J. 2016 Mar 21;37(12):942-54. doi: 10.1093/eurheartj/ehv512. Epub 2015 Oct 27.
9
[Pulmonary hypertension: hemodynamic evaluation: hemodynamic evaluation – recommendations of the Cologne Consensus Conference 2010].[肺动脉高压:血流动力学评估:血流动力学评估——2010年科隆共识会议推荐意见]
Dtsch Med Wochenschr. 2010 Oct;135 Suppl 3:S78-86. doi: 10.1055/s-0030-1263315. Epub 2010 Sep 22.
10
Pulmonary hypertension due to left heart disease.左心疾病所致肺动脉高压。
Eur Respir J. 2019 Jan 24;53(1). doi: 10.1183/13993003.01897-2018. Print 2019 Jan.

引用本文的文献

1
Echocardiographic evaluation of right heart failure which might be associated with DNA damage response in SU5416-hypoxia induced pulmonary hypertension rat model.超声心动图评价 SU5416 低氧诱导肺动脉高压大鼠模型右心衰竭与 DNA 损伤反应的关系。
Respir Res. 2023 Aug 17;24(1):202. doi: 10.1186/s12931-023-02501-7.
2
Features Associated With Discordance Between Pulmonary Arterial Wedge Pressure and Left Ventricular End Diastolic Pressure in Clinical Practice: Implications for Pulmonary Hypertension Classification.临床实践中肺小动脉楔压与左心室舒张末期压不相符的相关特征:对肺动脉高压分类的影响。
Chest. 2018 Nov;154(5):1099-1107. doi: 10.1016/j.chest.2018.08.1033. Epub 2018 Aug 24.

本文引用的文献

1
Macitentan in pulmonary hypertension due to left ventricular dysfunction.马西替坦治疗左心功能障碍所致肺动脉高压。
Eur Respir J. 2018 Feb 7;51(2). doi: 10.1183/13993003.01886-2017. Print 2018 Feb.
2
An official European Respiratory Society statement: pulmonary haemodynamics during exercise.欧洲呼吸学会官方声明:运动期间的肺血液动力学。
Eur Respir J. 2017 Nov 22;50(5). doi: 10.1183/13993003.00578-2017. Print 2017 Nov.
3
Haemodynamic effects of an acute vasodilator challenge in heart failure patients with reduced ejection fraction and different forms of post-capillary pulmonary hypertension.
心力衰竭伴射血分数降低和不同形式毛细血管后性肺动脉高压患者急性血管扩张剂挑战的血液动力学效应。
Eur J Heart Fail. 2018 Apr;20(4):725-734. doi: 10.1002/ejhf.1067. Epub 2017 Nov 16.
4
Is pulmonary artery wedge pressure a Fib in A-Fib?肺动脉楔压在房颤中是否等同于纤维蛋白原?
Eur J Heart Fail. 2017 Nov;19(11):1491-1494. doi: 10.1002/ejhf.992. Epub 2017 Sep 25.
5
Atrial fibrillation modifies the association between pulmonary artery wedge pressure and left ventricular end-diastolic pressure.心房颤动改变了肺动脉楔压与左心室舒张末期压之间的关联。
Eur J Heart Fail. 2017 Nov;19(11):1483-1490. doi: 10.1002/ejhf.959. Epub 2017 Sep 25.
6
Pulmonary hemodynamics in heart failure patients with reduced or preserved ejection fraction and pulmonary hypertension: Similarities and disparities.射血分数降低或保留且伴有肺动脉高压的心力衰竭患者的肺血流动力学:异同点
Am Heart J. 2017 Oct;192:120-127. doi: 10.1016/j.ahj.2017.06.006. Epub 2017 Jun 21.
7
Evaluation of criteria for exercise-induced pulmonary hypertension in patients with resting pulmonary hypertension.静息性肺动脉高压患者运动诱发肺动脉高压的标准评估。
Eur Respir J. 2017 Sep 20;50(3). doi: 10.1183/13993003.00784-2017. Print 2017 Sep.
8
What We Talk About When We Talk About the Wedge Pressure.当我们谈论楔压时我们在谈论什么。
Circ Heart Fail. 2017 Sep;10(9). doi: 10.1161/CIRCHEARTFAILURE.117.004450.
9
Thermodilution vs Estimated Fick Cardiac Output Measurement in Clinical Practice: An Analysis of Mortality From the Veterans Affairs Clinical Assessment, Reporting, and Tracking (VA CART) Program and Vanderbilt University.热稀释法与估计的 Fick 心输出量测量在临床实践中的比较:退伍军人事务部临床评估、报告和跟踪(VA CART)计划和范德比尔特大学的死亡率分析。
JAMA Cardiol. 2017 Oct 1;2(10):1090-1099. doi: 10.1001/jamacardio.2017.2945.
10
Use of thermodilution cardiac output overestimates diagnoses of exercise-induced pulmonary hypertension.热稀释法心输出量的使用高估了运动诱发性肺动脉高压的诊断。
Pulm Circ. 2017 Jan 1;7(1):253-255. doi: 10.1086/690629. eCollection 2017 Mar.